Research frontiers and hotspots of coronary chronic total occlusion: A bibliometric analysis
Shudi Li,Menghe Zhang,Wenwen Li,Zhenhai Sun,Yunxiao Zhang,Yaoyao Zuo,Shouqiang Chen
DOI: https://doi.org/10.1097/md.0000000000040537
IF: 1.6
2024-11-28
Medicine
Abstract:Chronic total occlusion (CTO) coronary artery disease is defined as the occurrence of complete occlusion of 1 or more coronary arteries, resulting in the interruption of forward blood flow, and the duration of occlusion is >3 months. [ 1 ] Coronary CTO lesions is a serious stage of coronary artery disease, and the clinical manifestations are dominated by chest tightness, chest pain, and other manifestations of coronary artery disease. CTO lesions can lead to angina pectoris, myocardial infarction, heart failure, and even sudden death. Epidemiologic investigation shows that the incidence of coronary CTO lesions in patients with conventional angiography is about 20%, [ 2 ] accounting for >30% of coronary heart disease, but <10% of patients receive surgical treatment. [ 3 ] Currently, there are 3 main treatment modalities for CTO lesions: drug therapy, coronary artery bypass grafting therapy, and percutaneous coronary intervention (PCI). [ 4 , 5 ] Interventional therapy has the advantages of less trauma and faster postoperative recovery, which is the key development direction of current surgical treatment and the most valuable treatment modality for research. [ 6–8 ] Studies have shown that recanalization of the coronary artery at occlusion can significantly reduce the incidence of adverse cardiovascular events. [ 9 , 10 ] However, it has been suggested that after the establishment of collateral circulation in the occluded coronary artery, the opening of the occluded coronary artery does not have much effect on the improvement of adverse outcomes in patients. [ 11 ] There are still many research gaps regarding the pathogenesis, natural history, and long-term prognosis of CTO lesions after recanalization. As well as the low recanalization rate, high restenosis rate, unclear long-term prognosis, and high risk of intraoperative complications, the treatment difficulties of CTO lesions have hindered the research process of this disease.
medicine, general & internal